VI
SGMO

VectorGlobal IAG’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

VectorGlobal IAG’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.61K Buy
+30,838
New +$12.3K ﹤0.01% 134

Other funds holding SGMO

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

VectorGlobal IAG's SGMO Position: Q1 2026 in Review

VectorGlobal IAG opened a new position in SANGAMO THERAPEUTICS INC (SGMO) in Q1 2026: 30,838 shares worth $7.61K. The stake represents ﹤0.01% of the portfolio and ranks #134 among its holdings.

112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • VectorGlobal IAG held 30,838 shares of SANGAMO THERAPEUTICS INC worth $7.61K as of Q1 2026.
  • SANGAMO THERAPEUTICS INC was a new VectorGlobal IAG position in Q1 2026.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of VectorGlobal IAG's portfolio in Q1 2026, its #134 holding.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on VectorGlobal IAG's 13F filing for Q1 2026, filed 30 Jun 2026.